Önder Albayrak is Deputy Head of Global Transfer Pricing & Tax Lead Benelux at Sanofi, a top health care company present in more than 100 countries. He has 17 years of experience in international taxation, during which he advised and supported corporate, regional and local management, operations, finance, treasury and legal teams and gained considerable expertise in the areas of international corporate taxation, intellectual property rights and intangible assets planning, supply chain and transfer pricing structuring, business expansions and restructurings, post-merger integrations, transfer pricing documentation, tax and transfer pricing controversy and negotiations with tax administrations.
Having studied Dutch Law and Tax Law at the University of Utrecht, Mr Albayrak started his career at Ernst & Young’s Multinationals Tax department and Transfer Pricing & TESCM team. In 2006, he changed from consultancy to industry and worked first as European Tax Manager and subsequently as Global Tax Manager at Genzyme, a former NASDAQ-listed US biotechnology company later acquired by Sanofi. Within Sanofi he served as Senior Tax & Transfer Pricing Manager for the Genzyme business and for Sanofi Benelux (2011-2014) and Senior Manager International Tax & Transfer Pricing for the Corporate Tax – Strategic & International Tax Affairs team in charge of Sanofi’s tax affairs for Western Europe, and as transfer pricing expert for Latin America and Asia (2015-2017).